Cited by 171Adipokines, Inflammation, and Metabolic DiseasesPancreatic function and diabetesAdipose Tissue and Metabolism

Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients

Open access
Hu, Hao, Sun, Wenjun, Yu, Shuqin, Hong, Xiafei, Qian, Weiyun, Tang, Bingqian, Wang, Dong, Yang, Ling +4 more·2014·Diabetes Care

Abstract

OBJECTIVE: Betatrophin, a newly identified hormone, has been recently characterized as a potent stimulator that increases the production and expansion of insulin-secreting β-cells in mice, but the physiological role of betatrophin remains poorly understood. This study measured for the first time serum betatrophin levels in newly diagnosed patients with type 2 diabetes (T2DM) and explored the correlations between its serum levels and various metabolic parameters in T2DM. RESEARCH DESIGN AND METHODS: We analyzed the concentrations of betatrophin by ELISA in blood samples of 166 well-characterized individuals in whom anthropometric parameters, oral glucose tolerance test (OGTT), glycosylated hemoglobin, blood lipids, insulin sensitivity (1/homeostasis model assesment of insulin resistance [1/HOMA-IR] and Matsuda index [ISIM]), and insulin secretion were measured. The participants were divided into newly diagnosed T2DM patients (n = 83) and age-, sex- and BMI-matched healthy control subjects (n = 83). RESULTS: Serum betatrophin levels were significantly higher in T2DM patients than in healthy control subjects (613.08 [422.19–813.08] vs. 296.57 [196.53–509.46] pg/mL; P < 0.01). Serum betatrophin positively correlated with age, 2-h post-OGTT glucose (2hPG), and postprandial serum insulin (PSI), but negatively with 1/HOMA-IR and ISIM in T2DM patients. In the control group, betatrophin was only positively associated with age. In T2DM subjects, multivariate regression analyses showed that age, 2hPG, and PSI were independent factors influencing serum betatrophin levels. CONCLUSIONS: Circulating concentrations of betatrophin are significantly increased in T2DM patients. Our results suggest that betatrophin may play a role in the pathogenesis of T2DM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-0602

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Betatrophin levels are higher in T2DM patients, although they were lower in one study.

    “This is substantiated by the fact that betatrophin levels are higher in T2DM patients,182, 183, 184 although they were lower in one study.185”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [182]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. Mazur MA, Winkler M, Ganic E, et al. Micro- phthalmia transcription factor regulates pan- creatic b-cell function. Diabetes 2013;62: 2834-2842
  2. Yi P, Park JS, Melton DA. Betatrophin: a hor- mone that controls pancreatic b cell prolifera- tion. Cell 2013;153:747-758

Cited by

Sorted by citations

Authors
Hu, H., Sun, W., Yu, S., Hong, X., Qian, W., Tang, B., Wang, D., Yang, L., Wang, J., Mao, C., Zhou, L., & Yuan, G.
Affiliations
  • Affiliated Hospital of Jiangsu University (CN)
  • Shanghai Jiao Tong University (CN)
Corresponding author
Yuan, Guoyue
Venue
Diabetes Care
Published
2014-09-10
Volume
37
Issue
10
Pages
2718-2722
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2116873891
Cited by
171
References
23
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 15 · 2019: 17 · 2018: 18 · 2017: 22 · 2016: 30 · 2015: 24 · 2014: 3
FWCI
19.93
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81370965)
  • Jiangsu University (81370965)
  • Government of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province (81370965, BK2009208)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
betatrophin, type 2 diabetes, newly diagnosed diabetes, serum hormone levels, insulin resistance, insulin secretion, postprandial blood glucose, beta-cell function, diabetes pathogenesis
MeSH terms
Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Adult, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Case-Control Studies, Postprandial Period, Peptide Hormones, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review